Connect with us

Business

WHO testing three new drugs artesunate, imatinib and infliximab against COVID in clinical trial – 7NEWS.com.au

A trio of anti-inflammatory drugs are being tested for use in virus patients.

Published

on

Article feature image

The World Health Organisation says a clinical trial in 52 countries will study three anti-inflammatory drugs as potential treatments for COVID-19 patients.
These therapies – artesunate, imatinib and infliximab – were selected by an independent expert panel…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending